company background image
4120 logo

Orient EuroPharma TPEX:4120 Stock Report

Last Price

NT$43.25

Market Cap

NT$3.8b

7D

2.7%

1Y

12.0%

Updated

13 Jun, 2024

Data

Company Financials

Orient EuroPharma Co., Ltd.

TPEX:4120 Stock Report

Market Cap: NT$3.8b

Orient EuroPharma Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Orient EuroPharma
Historical stock prices
Current Share PriceNT$43.25
52 Week HighNT$48.30
52 Week LowNT$35.65
Beta0.40
1 Month Change2.13%
3 Month Change4.22%
1 Year Change12.05%
3 Year Change-2.37%
5 Year Change-29.33%
Change since IPO243.48%

Recent News & Updates

Recent updates

Here's Why Orient EuroPharma (GTSM:4120) Has A Meaningful Debt Burden

Apr 04
Here's Why Orient EuroPharma (GTSM:4120) Has A Meaningful Debt Burden

Is Orient EuroPharma Co., Ltd.'s (GTSM:4120) 3.3% Dividend Worth Your Time?

Mar 04
Is Orient EuroPharma Co., Ltd.'s (GTSM:4120) 3.3% Dividend Worth Your Time?

A Look At Orient EuroPharma's (GTSM:4120) Share Price Returns

Feb 10
A Look At Orient EuroPharma's (GTSM:4120) Share Price Returns

Is Orient EuroPharma Co., Ltd.'s (GTSM:4120) Recent Performancer Underpinned By Weak Financials?

Jan 22
Is Orient EuroPharma Co., Ltd.'s (GTSM:4120) Recent Performancer Underpinned By Weak Financials?

We Think Orient EuroPharma (GTSM:4120) Can Stay On Top Of Its Debt

Jan 04
We Think Orient EuroPharma (GTSM:4120) Can Stay On Top Of Its Debt

A Look At The Fair Value Of Orient EuroPharma Co., Ltd. (GTSM:4120)

Dec 17
A Look At The Fair Value Of Orient EuroPharma Co., Ltd. (GTSM:4120)

Are Dividend Investors Getting More Than They Bargained For With Orient EuroPharma Co., Ltd.'s (GTSM:4120) Dividend?

Nov 29
Are Dividend Investors Getting More Than They Bargained For With Orient EuroPharma Co., Ltd.'s (GTSM:4120) Dividend?

Shareholder Returns

4120TW PharmaceuticalsTW Market
7D2.7%0.1%2.5%
1Y12.0%6.5%26.3%

Return vs Industry: 4120 exceeded the TW Pharmaceuticals industry which returned 6.5% over the past year.

Return vs Market: 4120 underperformed the TW Market which returned 26.3% over the past year.

Price Volatility

Is 4120's price volatile compared to industry and market?
4120 volatility
4120 Average Weekly Movement2.6%
Pharmaceuticals Industry Average Movement4.2%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.5%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 4120 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4120's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1982n/aPeter Tsaiwww.oepgroup.com

Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk and nutritional supplements under the Karihome, Babecare, and Ostricare brands; and healthcare supplements, such as thermal water for the treatment of oral and periodontal diseases under the Buccotherm name.

Orient EuroPharma Co., Ltd. Fundamentals Summary

How do Orient EuroPharma's earnings and revenue compare to its market cap?
4120 fundamental statistics
Market capNT$3.75b
Earnings (TTM)NT$26.28m
Revenue (TTM)NT$4.55b

142.8x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4120 income statement (TTM)
RevenueNT$4.55b
Cost of RevenueNT$2.39b
Gross ProfitNT$2.15b
Other ExpensesNT$2.13b
EarningsNT$26.28m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.30
Gross Margin47.33%
Net Profit Margin0.58%
Debt/Equity Ratio101.5%

How did 4120 perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

330%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.